Brief: Dynavax Technologies Q1 EPS USD -0.07
08/05/2024 21:01
May 08 (Reuters) - Dynavax Technologies Q1 operating expenses USD 68.559 million. * Q1 net income USD -8.721 million * Q1 operating income USD -17.769 million * Q1 pretax profit USD -11.497 million
Recent news on Dynavax Technologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
OneSpaWorld jumps as co poised to join S&P SmallCap index
Sanofi targets high single digit sales growth in 2026, plans share buyback (updated)
Focus: Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality